Standard Practice for The Sensory Evaluation of Axillary Deodorancy

SCOPE
1.1 This practice provides procedures which may be used in the design and analysis of studies to quantitatively assess the intensity of human axillary odor for the purpose of substantiating deodorant efficacy of personal care products.
1.2 This practice includes protocols for the selection and training of judges, selection of subjects, experimental design, and statistical analysis. This practice is limited to assessment of axillary odor by trained, second-party, judges. First-party or self-evaluation protocols are valid for selected sensory tasks but may be less sensitive.
1.3 With respect to the source of axillary odor, three groups of secretory glands are present in the axillae which participate to a greater or lesser extent in its production-eccrine, apocrine, and sebaceous. Axillary odor has been primarily ascribed to the apocrine gland secretion (1).  Body odor intensity has been correlated with the volume of the secretory portion of the apocrine gland (2) and the density of the glands.
1.3.1 Apocrine glands are found primarily in the axillary vault in conjunction with axillary hairs (3). Pure apocrine sweat is sterile and odorless and axillary odor results from degradation of apocrine sweat by resident skin bacteria (4). High bacterial populations are found in moist regions of the body, especially in the axillae, providing the appropriate environment for growth (5).
1.3.2 Eccrine glands keep the axillae moist through thermally and emotionally induced secretions (6).
1.3.3 The sebaceous glands excrete higher molecular weight lipid materials which absorb and retain the volatile materials resulting from bacterial action (7). The aerobic diphtheroids are able to produce the typical acrid axillary odor and the micrococcaceae produce an isovaleric acid-like odor when incubated with apocrine sweat (8). Therefore, the most undesirable component of axillary odor is caused by degradation of apocrine sweat by particular bacteria normally found in the axillary vault.
1.4 Personal care products are sold and used primarily for their ability to reduce the perception of body odor not only by the individual using the product but also by individuals within the scope of contact. Deodorant protection may be achieved by these products through various modes of action. Antiperspirants achieve their primary efficacy by means of the action of inorganic salts on the eccrine gland production of sweat. Antimicrobial agents achieve deodorancy by inhibiting the growth and activity of the microflora in the axillary vault thus reducing the microbial decomposition of sweat and the consequent production of body odor. Absorbents function either by "binding" available moisture or malodorous substances. Fragrances are effective by altering the perception of malodor and increasing the degree of "pleasantness." Other modes of control become important from time to time, representing changes in the state-of-the-art in product development.
1.5 The studies discussed herein are interpreted through the use of statistical tests of hypotheses. These hypotheses are usually of the form:

General Information

Status
Historical
Publication Date
09-Sep-1997
Current Stage
Ref Project

Relations

Buy Standard

Standard
ASTM E1207-87(1997) - Standard Practice for The Sensory Evaluation of Axillary Deodorancy
English language
16 pages
sale 15% off
Preview
sale 15% off
Preview

Standards Content (Sample)

NOTICE: This standard has either been superseded and replaced by a new version or discontinued.
Contact ASTM International (www.astm.org) for the latest information.
Designation: E 1207 – 87 (Reapproved 1997)
Standard Practice for
1
The Sensory Evaluation of Axillary Deodorancy
This standard is issued under the fixed designation E 1207; the number immediately following the designation indicates the year of
original adoption or, in the case of revision, the year of last revision. A number in parentheses indicates the year of last reapproval. A
superscript epsilon (e) indicates an editorial change since the last revision or reapproval.
1. Scope the scope of contact. Deodorant protection may be achieved by
these products through various modes of action. Antiperspi-
1.1 This practice provides procedures which may be used in
rants achieve their primary efficacy by means of the action of
the design and analysis of studies to quantitatively assess the
inorganic salts on the eccrine gland production of sweat.
intensity of human axillary odor for the purpose of substanti-
Antimicrobial agents achieve deodorancy by inhibiting the
ating deodorant efficacy of personal care products.
growth and activity of the microflora in the axillary vault thus
1.2 This practice includes protocols for the selection and
reducing the microbial decomposition of sweat and the conse-
training of judges, selection of subjects, experimental design,
quent production of body odor. Absorbents function either by
and statistical analysis. This practice is limited to assessment of
“binding” available moisture or malodorous substances. Fra-
axillary odor by trained, second-party, judges. First-party or
grances are effective by altering the perception of malodor and
self-evaluation protocols are valid for selected sensory tasks
increasing the degree of “pleasantness.” Other modes of
but may be less sensitive.
control become important from time to time, representing
1.3 With respect to the source of axillary odor, three groups
changes in the state-of-the-art in product development.
of secretory glands are present in the axillae which participate
1.5 The studies discussed herein are interpreted through the
to a greater or lesser extent in its production—eccrine, apo-
use of statistical tests of hypotheses. These hypotheses are
crine, and sebaceous. Axillary odor has been primarily ascribed
2 usually of the form:
to the apocrine gland secretion (1). Body odor intensity has
The Deodorant Efficacy of Treatment A
been correlated with the volume of the secretory portion of the
= The Deodorant Efficacy of Treatment B
apocrine gland (2) and the density of the glands.
1.5.1 It should be noted that failure to reject this hypothesis
1.3.1 Apocrine glands are found primarily in the axillary
vault in conjunction with axillary hairs (3). Pure apocrine at a specified level of significance does not prove the hypoth-
esis, but merely that the weight of evidence provided by the
sweat is sterile and odorless and axillary odor results from
degradation of apocrine sweat by resident skin bacteria (4). experiment is not sufficient to reject the hypothesis. This could
occur because either: a) The hypothesis is close to truth and
High bacterial populations are found in moist regions of the
great experimental power would be required to reject it, or b)
body, especially in the axillae, providing the appropriate
The experiment by design was low in power and, therefore,
environment for growth (5).
incapable of rejecting the hypothesis; even when it is far from
1.3.2 Eccrine glands keep the axillae moist through ther-
true. This can occur due to design structure or low sample size.
mally and emotionally induced secretions (6).
These facts must be taken into consideration when interpreting
1.3.3 The sebaceous glands excrete higher molecular weight
study results.
lipid materials which absorb and retain the volatile materials
resulting from bacterial action (7). The aerobic diphtheroids
2. Referenced Documents
are able to produce the typical acrid axillary odor and the
2.1 ASTM Standards:
micrococcaceae produce an isovaleric acid-like odor when
E 253 Terminology Relating to Sensory Evaluation of Ma-
incubated with apocrine sweat (8). Therefore, the most unde-
3
terials and Products
sirable component of axillary odor is caused by degradation of
apocrine sweat by particular bacteria normally found in the
3. Terminology
axillary vault.
3.1 Definitions of Terms Specific to This Standard:
1.4 Personal care products are sold and used primarily for
16
3.1.1 5-alpha-androst-16-en-3-one (delta (5-alpha)
their ability to reduce the perception of body odor not only by
androsten-3-one) C H O—CAS No. 18339-17-7—
the individual using the product but also by individuals within
19 28
component of axillary odor which has a “urinous” character
and results from the action of certain skin bacteria on apocrine
1
This practice is under the jurisdiction of ASTM Committee E-18 on Sensory
secretion (9).
Evalua
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.